1. Home
  2. LYRA vs EEIQ Comparison

LYRA vs EEIQ Comparison

Compare LYRA & EEIQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LYRA
  • EEIQ
  • Stock Information
  • Founded
  • LYRA 2005
  • EEIQ 2017
  • Country
  • LYRA United States
  • EEIQ United States
  • Employees
  • LYRA N/A
  • EEIQ N/A
  • Industry
  • LYRA Medical/Dental Instruments
  • EEIQ Other Consumer Services
  • Sector
  • LYRA Health Care
  • EEIQ Real Estate
  • Exchange
  • LYRA Nasdaq
  • EEIQ Nasdaq
  • Market Cap
  • LYRA 11.0M
  • EEIQ 13.0M
  • IPO Year
  • LYRA 2020
  • EEIQ 2021
  • Fundamental
  • Price
  • LYRA $0.17
  • EEIQ $1.12
  • Analyst Decision
  • LYRA Buy
  • EEIQ
  • Analyst Count
  • LYRA 5
  • EEIQ 0
  • Target Price
  • LYRA $4.50
  • EEIQ N/A
  • AVG Volume (30 Days)
  • LYRA 1.7M
  • EEIQ 114.6K
  • Earning Date
  • LYRA 11-12-2024
  • EEIQ 01-06-2025
  • Dividend Yield
  • LYRA N/A
  • EEIQ N/A
  • EPS Growth
  • LYRA N/A
  • EEIQ N/A
  • EPS
  • LYRA N/A
  • EEIQ N/A
  • Revenue
  • LYRA $1,471,000.00
  • EEIQ $6,454,461.00
  • Revenue This Year
  • LYRA N/A
  • EEIQ N/A
  • Revenue Next Year
  • LYRA N/A
  • EEIQ N/A
  • P/E Ratio
  • LYRA N/A
  • EEIQ N/A
  • Revenue Growth
  • LYRA 3.37
  • EEIQ 13.32
  • 52 Week Low
  • LYRA $0.16
  • EEIQ $0.60
  • 52 Week High
  • LYRA $6.79
  • EEIQ $2.18
  • Technical
  • Relative Strength Index (RSI)
  • LYRA 36.11
  • EEIQ 72.24
  • Support Level
  • LYRA $0.19
  • EEIQ $0.94
  • Resistance Level
  • LYRA $0.21
  • EEIQ $1.10
  • Average True Range (ATR)
  • LYRA 0.02
  • EEIQ 0.10
  • MACD
  • LYRA -0.00
  • EEIQ -0.00
  • Stochastic Oscillator
  • LYRA 6.42
  • EEIQ 85.60

About LYRA Lyra Therapeutics Inc.

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioresorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver up to six months of continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.

About EEIQ EpicQuest Education Group International Limited

EpicQuest Education Group International Ltd provides comprehensive education solutions for domestic and international students interested in university and college degree programs in the U.S., Canada, and the UK. In addition, the company has a recruiting relationship with the regional campuses of Miami University of Ohio, where it maintains residential facilities, a full-service cafeteria, recreational facilities, shuttle buses, and an office for the regional campuses that provides study abroad and post-study services for its students; these facilities are not owned, maintained, operated or are part of Miami University.

Share on Social Networks: